NCT00532103|CompletedDMC
Assessing Treatment Emergent Suicidal Ideation in Patients With Major Depression
SAMS
Suicide Assessment Methodology Study (SAMS)
Loading search results
SAMS
Suicide Assessment Methodology Study (SAMS)
Sponsor study identifier
Secondary identifiers
NIH
observational
300
1 country
15
Study Start
July 2007
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
February 2008
Actual (reported)Study Completion
February 2008
Actual (reported)This study will develop a new methodology to evaluate any treatment-emergent suicidal ideation that might occur when an antidepressant treatment has been started and/or during times when doses are increased in patients with major depressive disorder.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
February 2008
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 2007
Date type not reportedThis date has not been verified as actual or estimated.
September 18, 2007
Actual (reported)September 19, 2007
Actual (reported)February 2008
Actual (reported)February 2008
Actual (reported)Fifteen primary care and specialty care clinics across the country.
Tuscalossa VA Mental Health Clinic
Tuscaloosa, Alabama, 35404, United States
Harbor UCLA Family Health Care Center
Harbor City, California, 90710, United States
UCLA Internal Medicine Clinic
Los Angeles, California, 90024, United States
Veterans Affairs Medical Center/FIRM Primary Care Clinic
San Diego, California, 92161, United States
Northwestern Psychiatric Outpatient Treatment Care Center
Chicago, Illinois, 60611, United States
Clinical Research Institute
Wichita, Kansas, 67214, United States
MGH/Northshore Medical Center (Salem Psychiatric Facility)
Jha MK, Minhajuddin A, South C, Rush AJ, Trivedi MH. Irritability and Its Clinical Utility in Major Depressive Disorder: Prediction of Individual-Level Acute-Phase Outcomes Using Early Changes in Irritability and Depression Severity. Am J Psychiatry. 2019 May 1;176(5):358-366. doi: 10.1176/appi.ajp.2018.18030355. Epub 2019 Mar 29.
Gollan JK, Fava M, Kurian B, Wisniewski SR, Rush AJ, Daly E, Miyahara S, Trivedi MH. What are the clinical implications of new onset or worsening anxiety during the first two weeks of SSRI treatment for depression? Depress Anxiety. 2012 Feb;29(2):94-101. doi: 10.1002/da.20917. Epub 2011 Dec 6.
Madhukar Trivedi, MD
University of Texas Southwestern Medical Center
Stephen R. Wisniewski, PhD
University of Pittsburgh
Diane Warden, PhD, MBA
University of Texas Southwestern Medical Center
Kathy Shores-Wilson, PhD
University of Texas Southwestern Medical Center
First Submitted
September 18, 2007
First Posted
September 19, 2007
Study Start
July 2007
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
February 2008
Actual (reported)Treatment Response of Geriatric Depression
Contact the study team to confirm eligibility.
Salem, Massachusetts, 01970, United States
General Psychiatric Ambulatory Clinic
Ann Arbor, Michigan, 48105, United States
Irving Goldman Primary Care at North Shore Hospital
New York, New York, 11040, United States
UNC Chapel Hill Adult Diagnostic & Treatment Clinic
Chapel Hill, North Carolina, 27599-7160, United States
Laureate Psychiatric Clinic and Hospital
Tulsa, Oklahoma, 74135, United States
Bellefield Clinic of WPIC
Pittsburgh, Pennsylvania, 15213, United States
Vine Hill Community Clinic
Nashville, Tennessee, 37212, United States
UT Southwestern Family Medicine Clinic
Dallas, Texas, 75390, United States
VCU Outpatient Psychiatry Clinic
Richmond, Virginia, 23298, United States
Trivedi MH, Wisniewski SR, Morris DW, Fava M, Kurian BT, Gollan JK, Nierenberg AA, Warden D, Gaynes BN, Luther JF, Rush AJ. Concise Associated Symptoms Tracking scale: a brief self-report and clinician rating of symptoms associated with suicidality. J Clin Psychiatry. 2011 Jun;72(6):765-74. doi: 10.4088/JCP.11m06840.
Trivedi MH, Wisniewski SR, Morris DW, Fava M, Gollan JK, Warden D, Nierenberg AA, Gaynes BN, Husain MM, Luther JF, Zisook S, Rush AJ. Concise Health Risk Tracking scale: a brief self-report and clinician rating of suicidal risk. J Clin Psychiatry. 2011 Jun;72(6):757-64. doi: 10.4088/JCP.11m06837.
Warden D, Trivedi MH, Wisniewski SR, Kurian B, Zisook S, Kornstein SG, Friedman ES, Miyahara S, Leuchter AF, Fava M, Rush AJ. Early adverse events and attrition in selective serotonin reuptake inhibitor treatment: a suicide assessment methodology study report. J Clin Psychopharmacol. 2010 Jun;30(3):259-66. doi: 10.1097/JCP.0b013e3181dbfd04.
David W. Morris, PhD
University of Texas Southwestern Medical Center
Study Completion
February 2008
Actual (reported)Last Updated
September 22, 2008
Record last verified: 2008-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: